Evidence map›Paper›PMID 30367375›Full record

ArticleInternational journal of clinical pharmacy2018

Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.

Jean-Pierre Jourdan, Alexandra Muzard, Isabelle Goyer, Yann Ollivier, Youssef Oulkhouir, Patrick Henri, Jean-Jacques Parienti, Cécile Breuil

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2025
    Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Pharmacists' interventions on prescribing errors in Malaysia.Journal of pharmaceutical policy and practice · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2022
    Article
  19. Value of a Pharmacy-Adjudicated Community Care Prior Authorization Drug Request Service.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jean-Pierre JourdanDepartment of Pharmacy, Caen UHC, 14000, Caen, France. jourdan-jp@chu-caen.fr.ORCID http://orcid.org/0000-0002-0553-9705
Alexandra MuzardDepartment of Pharmacy, Caen UHC, 14000, Caen, France.
Isabelle GoyerDepartment of Pharmacy, Caen UHC, 14000, Caen, France.
Yann OllivierDepartment of Internal Medicine, Caen UHC, 14000, Caen, France.
Youssef OulkhouirDepartment of Chest Medicine, Caen UHC, 14000, Caen, France.
Patrick HenriRenal Disease Teaching Center, Caen UHC, 14000, Caen, France.
Jean-Jacques ParientiClinical Research and Innovation Division, Caen UHC, 14000, Caen, France.
Cécile BreuilDepartment of Pharmacy, Caen UHC, 14000, Caen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background A significant number of clinical pharmacy services have shown to improve in-hospital medication safety and patient outcome. Prescription review and pharmacist interventions are a fundamental part of hospital clinical pharmacy activities. In a context of restricted financial resources, proving the economic and clinical impact of this activity seems necessary. Objective The aim of this study was to assess the clinical impact on patient outcomes and economic benefit of prescription review by pharmacists. Setting 1624-bed tertiary French university teaching hospital. Method Prospective single center study evaluating prescriptions for which a pharmacist intervention was issued over a 6-month period. The clinical impact of every pharmacist intervention was evaluated by a multidisciplinary experts committee. Economic benefit was evaluated from the public health care system spending standpoint. Main outcome measures Number of avoided hospitalization days and associated public health care system cost-avoidance. Results Prescription review and interventions by pharmacists prevented 73 intensive care unit hospitalization days, 74 continuous monitoring unit hospitalization days and 66 days of conventional hospitalization. €252,294.00 in public health expenditure were thus prevented. For every Euro invested in the prescription review activity, €5.09 of public health spending were potentially saved. Conclusion Our study shows that prescription review and clinical pharmacists' interventions had an impact on clinical outcomes which translated into prevented hospitalization days. Prescription optimization through pharmacist interventions allows significant health care cost savings which makes this service highly efficient.

Indexed as

PharmacistsTreatment OutcomeAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCost ControlCost SavingsDrug PrescriptionsFemaleHospitalizationHospitals, TeachingHospitals, UniversityHumansClinical pharmacy servicesFranceHealth care costsPharmacist InterventionsPresciption review

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.